Dechert, Sullivan Steer CVS To $2.1B Infusion Biz Buy

Law360, New York (November 27, 2013, 11:13 AM EST) -- Drugstore chain CVS Caremark Corp. will put up $2.1 billion for the private equity-backed infusion unit of Apria Healthcare Group Inc. in a move that will help flesh out its specialty pharmacy offerings and drive new growth, CVS said Wednesday.

Rhode Island-based CVS did not give a financing breakdown for the transaction or sketch out the deal's terms. The acquisition will add roughly $1.4 billion in revenues in the first year after the deal closes, expected in the first quarter of 2014 pending regulatory approval, the...
To view the full article, register now.